⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FGEN News
FibroGen, Inc
Advancements in CKD Care: How New Therapies from AstraZeneca, Johnson & Johnson, Novartis, Bayer, and Amgen Are Changing the Landscape
globenewswire.com
AMGN
AZN
JNJ
NVS
ABBV
AKBA
ARDX
CHNR
LLY
FGEN
GILD
GSK
NVO
PFE
IVD Raw Materials Market Report Just Released — Forecasts Expansion from $30.16B in 2026 to $43.76B in 2030
globenewswire.com
MRK
TMO
BIO
NEOG
FGEN
Fluidra Appoints Juan Graham as Chief Financial Officer
businesswire.com
FGEN
Freenome's SimpleScreen™ CRC Blood-Based Test Included in Updated ACS Colorectal Cancer Screening Guideline
prnewswire.com
ABT
FGEN
Idiopathic Pulmonary Fibrosis Market Dynamics, Opportunity Analysis and Forecast Report 2026-2035: Therapeutic Landscape is Anchored by Two Key Products - Esbriet (Pirfenidone), and Ofev
globenewswire.com
BIIB
AZN
FGEN
Industry Leader Francisco De La Vega Joins Ultima to Accelerate Advancements in Germline Genome Sequencing
prnewswire.com
FGEN
Cellular Health Screening Research Report 2026 - Global Market Analysis, Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031
globenewswire.com
FGEN
Freenome Reports Data for Multiomic Blood-Based Screening Test for Lung Cancer
prnewswire.com
FGEN
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results
globenewswire.com
KYNB
FGEN
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
globenewswire.com
KYNB
FGEN